Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases - Di Giacomo, A M; Danielli, R; Guidoboni, M (Cancer Immunol Immunother, 2009)